109 related articles for article (PubMed ID: 37507258)
1. Temporal Variation of Treatment Patterns and Survival Outcomes of Triple-Negative Breast Cancer Patients: A Real-World Experience From 2000 to 2014.
Valcarcel B; Torres-Roman JS; Enriquez D; Vidaurre T; De la Cruz-Ku G
Clin Breast Cancer; 2023 Oct; 23(7):737-745.e5. PubMed ID: 37507258
[TBL] [Abstract][Full Text] [Related]
2. Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis.
Huang M; O'Shaughnessy J; Zhao J; Haiderali A; Cortés J; Ramsey SD; Briggs A; Hu P; Karantza V; Aktan G; Qi CZ; Gu C; Xie J; Yuan M; Cook J; Untch M; Schmid P; Fasching PA
Cancer Res; 2020 Dec; 80(24):5427-5434. PubMed ID: 32928917
[TBL] [Abstract][Full Text] [Related]
3. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
4. Real-world treatment patterns and effectiveness outcomes in patients with early-stage triple-negative breast cancer.
Haiderali A; Rhodes WC; Gautam S; Huang M; Sieluk J; Skinner KE; Schwartzberg LS
Future Oncol; 2021 Oct; 17(29):3819-3831. PubMed ID: 34227400
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database.
Bagegni NA; Tao Y; Ademuyiwa FO
PLoS One; 2019; 14(9):e0222358. PubMed ID: 31536530
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation.
Keilty D; Nezafat Namini S; Swain M; Maganti M; Cil TD; McCready DR; Cescon DW; Amir E; Fleming R; Mulligan AM; Fyles A; Croke JM; Liu FF; Levin W; Koch CA; Han K
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):676-685. PubMed ID: 32407932
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns, healthcare resource utilization and outcomes for early stage triple-negative breast cancer in Japan.
Sanno H; Taniguchi K; Yoshimoto Y; Saji S
Future Oncol; 2024 Apr; 20(13):833-849. PubMed ID: 38305038
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of concurrent docetaxel and epirubicin neoadjuvant versus adjuvant chemotherapy: Which leads to better outcomes for different subtype breast cancer patients?
Yang H; Zhou L; Wang S; Cao Y; Tong F; Liu P; Zhou B; Cheng L; Liu M; Liu H; Xie F; Guo J; Wang S; Peng Y
Medicine (Baltimore); 2018 Oct; 97(40):e12690. PubMed ID: 30290661
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
Clifton K; Gutierrez-Barrera A; Ma J; Bassett R; Litton J; Kuerer H; Moulder S; Albarracin C; Hortobagyi G; Arun B
Breast Cancer Res Treat; 2018 Jul; 170(1):101-109. PubMed ID: 29470805
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
[TBL] [Abstract][Full Text] [Related]
11. Healthcare resource utilization and cost among patients treated for early-stage triple-negative breast cancer.
Haiderali A; Rhodes WC; Gautam S; Huang M; Sieluk J; Skinner KE; Schwartzberg LS
Future Oncol; 2021 Oct; 17(29):3833-3841. PubMed ID: 34254533
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.
Du ZL; Wang Y; Wang DY; Zhang L; Bian ZM; Deng Y; Xu CS; Lin DC; Xie L; Jia Y; Gao JD; Zhang BL
Breast Cancer Res Treat; 2020 Sep; 183(2):429-438. PubMed ID: 32647940
[TBL] [Abstract][Full Text] [Related]
13. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
[TBL] [Abstract][Full Text] [Related]
14. Real-life clinical pattern, management, and survival in Thai patients with early-stage or metastatic triple-negative breast cancer.
Srimuninnimit V; Pornpraserthsuk P; Chaiwerawattana A; Kongdan Y; Namkanisorn T; Somwangprasert A; Jatuparisuthi C; Puttawibul P; Vongsaisuwan M; Thongthieang L; Bandidwattanawong C; Tantimongkolsuk C
PLoS One; 2018; 13(12):e0209040. PubMed ID: 30566471
[TBL] [Abstract][Full Text] [Related]
15. Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?
Hatzipanagiotou ME; Pigerl M; Gerken M; Räpple S; Zeltner V; Hetterich M; Ugocsai P; Fernandez-Pacheco M; Inwald EC; Klinkhammer-Schalke M; Ortmann O; Seitz S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11941-11950. PubMed ID: 37418056
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of male triple negative breast cancer: A population-based study.
Ghani S; Sochat M; Luo J; Tao Y; Ademuyiwa F
Breast J; 2020 Sep; 26(9):1748-1755. PubMed ID: 32856383
[TBL] [Abstract][Full Text] [Related]
17. Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience.
De-la-Cruz-Ku G; Luyo M; Morante Z; Enriquez D; Möller MG; Chambergo-Michilot D; Flores L; Luque R; Saavedra A; Eyzaguirre-Sandoval ME; Luján-Peche MG; Noel N; Calderon H; Razuri C; Fuentes HA; Cotrina JM; Neciosup SP; Araujo J; Lema A; Pinto J; Gomez HL; Valcarcel B
PLoS One; 2020; 15(8):e0237811. PubMed ID: 32833983
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer.
Gagliato Dde M; Gonzalez-Angulo AM; Lei X; Theriault RL; Giordano SH; Valero V; Hortobagyi GN; Chavez-Macgregor M
J Clin Oncol; 2014 Mar; 32(8):735-44. PubMed ID: 24470007
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics, risk factors, and outcomes in Chilean triple negative breast cancer patients: a real-world study.
Acevedo F; Walbaum B; Medina L; Merino T; Camus M; Puschel K; Ramírez K; Manzor M; Veglia P; Martinez R; Guerra C; Navarro M; Bauerle C; Dominguez F; Sánchez C
Breast Cancer Res Treat; 2023 Jan; 197(2):449-459. PubMed ID: 36414796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
